These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 7680960)

  • 41. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
    Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
    Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
    Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
    Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2.
    Huyer G; Li ZM; Adam M; Huckle WR; Ramachandran C
    Biochemistry; 1995 Jan; 34(3):1040-9. PubMed ID: 7530043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data.
    Mikol V; Baumann G; Zurini MG; Hommel U
    J Mol Biol; 1995 Nov; 254(1):86-95. PubMed ID: 7473762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examination of the dephosphorylation reactions catalyzed by pp60c-src tyrosine kinase explores the roles of autophosphorylation and SH2 ligand binding.
    Boerner RJ; Kassel DB; Edison AM; Knight WB
    Biochemistry; 1995 Nov; 34(45):14852-60. PubMed ID: 7578095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cooperative self-assembly of SH2 domain fragments restores phosphopeptide binding.
    Williams KP; Shoelson SE
    Biochemistry; 1993 Oct; 32(42):11279-84. PubMed ID: 7692962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
    Charifson PS; Shewchuk LM; Rocque W; Hummel CW; Jordan SR; Mohr C; Pacofsky GJ; Peel MR; Rodriguez M; Sternbach DD; Consler TG
    Biochemistry; 1997 May; 36(21):6283-93. PubMed ID: 9174343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85.
    Koegl M; Kypta RM; Bergman M; Alitalo K; Courtneidge SA
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):737-44. PubMed ID: 7524477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains.
    Sheinerman FB; Al-Lazikani B; Honig B
    J Mol Biol; 2003 Dec; 334(4):823-41. PubMed ID: 14636606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An investigation of phosphopeptide binding to SH2 domain.
    Lee JK; Moon T; Chi MW; Song JS; Choi YS; Yoon CN
    Biochem Biophys Res Commun; 2003 Jun; 306(1):225-30. PubMed ID: 12788092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.
    Shakespeare W; Yang M; Bohacek R; Cerasoli F; Stebbins K; Sundaramoorthi R; Azimioara M; Vu C; Pradeepan S; Metcalf C; Haraldson C; Merry T; Dalgarno D; Narula S; Hatada M; Lu X; van Schravendijk MR; Adams S; Violette S; Smith J; Guan W; Bartlett C; Herson J; Iuliucci J; Weigele M; Sawyer T
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9373-8. PubMed ID: 10944210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
    Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
    J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide.
    Olejniczak ET; Zhou MM; Fesik SW
    Biochemistry; 1997 Apr; 36(14):4118-24. PubMed ID: 9100005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SH2 domain specificity and activity modified by a single residue.
    Marengere LE; Songyang Z; Gish GD; Schaller MD; Parsons JT; Stern MJ; Cantley LC; Pawson T
    Nature; 1994 Jun; 369(6480):502-5. PubMed ID: 7515480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.